Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe AI in Pathology Market, by Neural Network
1.4.2 Europe AI in Pathology Market, by Application
1.4.3 Europe AI in Pathology Market, by End User
1.4.4 Europe AI in Pathology Market, by Component
1.4.5 Europe AI in Pathology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 Market Share Analysis, 2022
4.2 Recent Strategies Deployed in AI in Pathology Market
4.3 Porter’s Five Forces Analysis
Chapter 5. Europe AI in Pathology Market, By Neural Network
5.1 Europe Convolutional neural networks (CNNs) Market, By Country
5.2 Europe Generative adversarial networks (GANs) Market, By Country
5.3 Europe Recurrent neural networks (RNNs) Market, By Country
5.4 Europe Others Market, By Country
Chapter 6. Europe AI in Pathology Market, By Application
6.1 Europe Drug Discovery Market, By Country
6.2 Europe Disease Diagnosis & Prognosis Market, By Country
6.3 Europe Clinical Workflow Market, By Country
6.4 Europe Others Market, By Country
Chapter 7. Europe AI in Pathology Market, By End User
7.1 Europe Pharmaceutical & Biotechnology Companies Market, By Country
7.2 Europe Hospitals & Reference Laboratories Market, By Country
7.3 Europe Academic & Research Institutes Market, By Country
Chapter 8. Europe AI in Pathology Market, By Component
8.1 Europe Scanners Market, By Country
8.2 Europe Software Market, By Country
Chapter 9. Europe AI in Pathology Market, By Country
9.1 Germany AI in Pathology Market
9.1.1 Germany AI in Pathology Market, By Neural Network
9.1.2 Germany AI in Pathology Market, By Application
9.1.3 Germany AI in Pathology Market, By End User
9.1.4 Germany AI in Pathology Market, By Component
9.2 UK AI in Pathology Market
9.2.1 UK AI in Pathology Market, By Neural Network
9.2.2 UK AI in Pathology Market, By Application
9.2.3 UK AI in Pathology Market, By End User
9.2.4 UK AI in Pathology Market, By Component
9.3 France AI in Pathology Market
9.3.1 France AI in Pathology Market, By Neural Network
9.3.2 France AI in Pathology Market, By Application
9.3.3 France AI in Pathology Market, By End User
9.3.4 France AI in Pathology Market, By Component
9.4 Russia AI in Pathology Market
9.4.1 Russia AI in Pathology Market, By Neural Network
9.4.2 Russia AI in Pathology Market, By Application
9.4.3 Russia AI in Pathology Market, By End User
9.4.4 Russia AI in Pathology Market, By Component
9.5 Spain AI in Pathology Market
9.5.1 Spain AI in Pathology Market, By Neural Network
9.5.2 Spain AI in Pathology Market, By Application
9.5.3 Spain AI in Pathology Market, By End User
9.5.4 Spain AI in Pathology Market, By Component
9.6 Italy AI in Pathology Market
9.6.1 Italy AI in Pathology Market, By Neural Network
9.6.2 Italy AI in Pathology Market, By Application
9.6.3 Italy AI in Pathology Market, By End User
9.6.4 Italy AI in Pathology Market, By Component
9.7 Rest of Europe AI in Pathology Market
9.7.1 Rest of Europe AI in Pathology Market, By Neural Network
9.7.2 Rest of Europe AI in Pathology Market, By Application
9.7.3 Rest of Europe AI in Pathology Market, By End User
9.7.4 Rest of Europe AI in Pathology Market, By Component
Chapter 10. Company Profiles
10.1 Koninklijke Philips N.V.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.6 SWOT Analysis
10.2 F. Hoffmann-La Roche Ltd.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.6 SWOT Analysis
10.3 Hologic, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Product Launches and Product Expansions:
10.3.6 SWOT Analysis
10.4 Visiopharm A/S
10.4.1 Company Overview
10.4.2 Recent strategies and developments:
10.4.2.1 Partnerships, Collaborations, and Agreements:
10.4.3 SWOT Analysis
10.5 Paige AI, Inc.
10.5.1 Company Overview
10.5.2 Recent strategies and developments:
10.5.2.1 Partnerships, Collaborations, and Agreements:
10.5.2.2 Product Launches and Product Expansions:
10.5.3 SWOT Analysis
10.6 PathAI, Inc.
10.6.1 Company Overview
10.6.2 Recent strategies and developments:
10.6.2.1 Partnerships, Collaborations, and Agreements:
10.6.3 SWOT Analysis
10.7 Aiforia Technologies Plc
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Recent strategies and developments:
10.7.3.1 Partnerships, Collaborations, and Agreements:
10.7.4 SWOT Analysis
10.8 Indica Labs, Inc.
10.8.1 Company Overview
10.8.2 Recent strategies and developments:
10.8.2.1 Partnerships, Collaborations, and Agreements:
10.8.3 SWOT Analysis
10.9 Optrascan, Inc. (Optra Ventures, LLC)
10.9.1 Company Overview
10.9.2 Recent strategies and developments:
10.9.2.1 Partnerships, Collaborations, and Agreements:
10.9.2.2 Product Launches and Product Expansions:
10.9.3 SWOT Analysis
10.10. MindPeak GmbH
10.10.1 Company Overview
10.10.2 Recent strategies and developments:
10.10.2.1 Partnerships, Collaborations, and Agreements:
10.10.3 SWOT Analysis
Unique Offerings 